Ripretinib in patients with advanced gastrointestinal stromal tumours (INVICTUS): a double-blind, randomised, placebo-controlled, phase 3 trial.
- DOI
- 10.1016/s1470-2045(20)30168-6
- Published
- 2020 Jul
- Container
- The Lancet. Oncology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/s1470-2045-20-30168-6,
title = {Ripretinib in patients with advanced gastrointestinal stromal tumours (INVICTUS): a double-blind, randomised, placebo-controlled, phase 3 trial.},
author = {Blay JY and Serrano C and Heinrich MC and Zalcberg J and Bauer S and Gelderblom H and Schöffski P and Jones RL and Attia S and D'Amato G and Chi P and Reichardt P and Meade J and Shi K and Ruiz-Soto R and George S and von Mehren M},
year = {2020},
journal = {The Lancet. Oncology},
doi = {10.1016/s1470-2045(20)30168-6},
url = {https://doi.org/10.1016/s1470-2045(20)30168-6}
}RIS
TY - JOUR TI - Ripretinib in patients with advanced gastrointestinal stromal tumours (INVICTUS): a double-blind, randomised, placebo-controlled, phase 3 trial. AU - Blay JY AU - Serrano C AU - Heinrich MC AU - Zalcberg J AU - Bauer S AU - Gelderblom H AU - Schöffski P AU - Jones RL AU - Attia S AU - D'Amato G AU - Chi P AU - Reichardt P AU - Meade J AU - Shi K AU - Ruiz-Soto R AU - George S AU - von Mehren M PY - 2020 JO - The Lancet. Oncology DO - 10.1016/s1470-2045(20)30168-6 UR - https://doi.org/10.1016/s1470-2045(20)30168-6 ER -
APA
JY, B., C, S., MC, H., J, Z., S, B., H, G., P, S., RL, J., S, A., G, D., P, C., P, R., J, M., K, S., R, R., S, G., & M, V. M. (2020). Ripretinib in patients with advanced gastrointestinal stromal tumours (INVICTUS): a double-blind, randomised, placebo-controlled, phase 3 trial.. The Lancet. Oncology. https://doi.org/10.1016/s1470-2045(20)30168-6
Source records
- pubmed · retrieved 2026-09-26T06:55:29.743Z